NCCN Categories of Evidence and Consensus
Category 1: Based upon high-level evidence, there is uniform NCCN consensus that the intervention is appropriate.
Category 2A: Based upon lower-level evidence, there is uniform NCCN consensus that the intervention is appropriate.
Category 2B: Based upon lower-level evidence, there is NCCN consensus that the intervention is appropriate.
Category 3: Based upon any level of evidence, there is major NCCN disagreement that the intervention is appropriate.
All recommendations are category 2A unless otherwise noted.
Clinical trials: NCCN believes that the best management for any cancer patient is in a clinical trial. Participation in clinical trials is especially encouraged.
CarrDGoudasLLawrenceD. Management of Cancer Symptoms: Pain Depression and Fatigue. Evidence Report/Technology Assessment No. 61 (Prepared by the New England Medical Center Evidence-based Practice Center under Contract No 290-97-0019). AHRQ Publication No. 02-E032. Rockville, MD: Agency for Healthcare Research and Quality. July2002. Available at: http://archive.ahrq.gov/downloads/pub/evidence/pdf/cansymp/cansymp.pdf. Accessed January 9 2013.
CleelandCSBennettGJDantzerR. Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms. Cancer2003;97:2919–2925.
DantzerRO'ConnorJCFreundGG. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci2008;9:46–56.
HegelMTMooreCPCollinsED. Distress, psychiatric syndromes, and impairment of function in women with newly diagnosed breast cancer. Cancer2006;107:2924–2931.
LindenWVodermaierAMackenzieRGreigD. Anxiety and depression after cancer diagnosis: prevalence rates by cancer type, gender, and age. J Affect Disord2012;141:343–351.
MitchellAJChanMBhattiH. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol2011;12:160–174.
PartridgeAHWangPSWinerEPAvornJ. Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer. J Clin Oncol2003;21:602–606.
DiMatteoMRLepperHSCroghanTW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med2000;160:2101–2107.
CarlsonLEBultzBD. Efficacy and medical cost offset of psychosocial interventions in cancer care: making the case for economic analyses. Psychooncology2004;13:837–849; discussion 850–836.
BrownKWLevyARRosbergerZEdgarL. Psychological distress and cancer survival: a follow-up 10 years after diagnosis. Psychosom Med2003;65:636–643.
KissaneD. Beyond the psychotherapy and survival debate: the challenge of social disparity, depression and treatment adherence in psychosocial cancer care. Psychooncology2009;18:1–5.
CarmackCLBasen-EngquistKGritzER. Survivors at higher risk for adverse late outcomes due to psychosocial and behavioral risk factors. Cancer Epidemiol Biomarkers Prev2011;20:2068–2077.
ZaboraJR. Screening procedures for psychosocial distress. In: HollandJCBreitbartWJacobsenPB eds. Psycho Oncology. New York, NY: Oxford University Press; 1998:653–661.
CarlsonLEGroffSLMaciejewskiOBultzBD. Screening for distress in lung and breast cancer outpatients: a randomized controlled trial. J Clin Oncol2010;28:4884–4891.
Kadan-LottickNSVanderwerkerLCBlockSD. Psychiatric disorders and mental health service use in patients with advanced cancer: a report from the coping with cancer study. Cancer2005;104:2872–2881.
SharpeMStrongVAllenK. Major depression in outpatients attending a regional cancer centre: screening and unmet treatment needs. Br J Cancer2004;90:314–320.
FallowfieldLRatcliffeDJenkinsVSaulJ. Psychiatric morbidity and its recognition by doctors in patients with cancer. Br J Cancer2001;84:1011–1015.
HollandJC. American Cancer Society Award lecture. Psychological care of patients: psycho-oncology's contribution. J Clin Oncol2003;21:253s–265s.
FitchettGHandzoG. Spiritual assessment, screening, and intervention. In: HollandJCBreitbartWJacobsenPB eds. Psycho Oncology. New York: Oxford University Press; 1998:790–808.
HollandJCGreenbergDBHughesMK. Quick Reference for Oncology Clinicians: The Psychiatric and Psychological Dimensions of Cancer Symptom Management. Charlottesville, VA: IPOS press; 2006.
JacobsenPBJimHS. Psychosocial interventions for anxiety and depression in adult cancer patients: achievements and challenges. CA Cancer J Clin2008;58:214–230.
Quality improvement guidelines for the treatment of acute pain and cancer pain. American Pain Society Quality of Care Committee. JAMA1995;274:1874–1880.
NeussMNDeschCEMcNiffKK. A process for measuring the quality of cancer care: the Quality Oncology Practice Initiative. J Clin Oncol2005;23:6233–6239.
JacobsonJONeussMNMcNiffKK. Improvement in oncology practice performance through voluntary participation in the Quality Oncology Practice Initiative. J Clin Oncol2008;26:1893–1898.
BlayneyDWMcNiffKHanauerD. Implementation of the Quality Oncology Practice Initiative at a university comprehensive cancer center. J Clin Oncol2009;27:3802–3807.
CarlsonLEWallerAMitchellAJ. Screening for distress and unmet needs in patients with cancer: review and recommendations. J Clin Oncol2012;30:1160–1177.
BultzBDGroffSLFitchM. Implementing screening for distress, the 6th vital sign: a Canadian strategy for changing practice. Psychooncology2011;20:463–469.
DolbeaultSBoistardBMeuricJ. Screening for distress and supportive care needs during the initial phase of the care process: a qualitative description of a clinical pilot experiment in a French cancer center. Psychooncology2011;20:585-593.
GrassiLRossiECarusoR. Educational intervention in cancer outpatient clinics on routine screening for emotional distress: an observational study. Psychooncology2011;20:669–674.
MitchellAJ. Pooled results from 38 analyses of the accuracy of distress thermometer and other ultra-short methods of detecting cancer-related mood disorders. J Clin Oncol2007;25:4670–4681.
ZaboraJBrintzenhofeSzocKJacobsenP. A new psychosocial screening instrument for use with cancer patients. Psychosomatics2001;42:241–246.
MitchellAJKaarSCogganCHerdmanJ. Acceptability of common screening methods used to detect distress and related mood disorders-preferences of cancer specialists and non-specialists. Psychooncology2008;17:226–236.
MitchellAJ. Short screening tools for cancer-related distress: a review and diagnostic validity meta-analysis. J Natl Compr Canc Netw2010;8:487–494.
CarlsonLEWallerAGroffSL. Online screening for distress, the 6th vital sign, in newly diagnosed oncology outpatients: randomised controlled trial of computerised vs personalised triage. Br J Cancer2012;107:617–625.
MillerMFBuzagloJSClarkKL. Demonstrating the psychometric properties of a problem-related distress screener in a community sample of 319 cancer survivors. Psychooncologyin press.
MitchellAJMeaderNDaviesE. Meta-analysis of screening and case finding tools for depression in cancer: evidence based recommendations for clinical practice on behalf of the Depression in Cancer Care consensus group. J Affect Disord2012;140:149–160.
AkizukiNAkechiTNakanishiT. Development of a brief screening interview for adjustment disorders and major depression in patients with cancer. Cancer2003;97:2605–2613.
DabrowskiMBoucherKWardJH. Clinical experience with the NCCN Distress Thermometer in breast cancer patients. J Natl Compr Canc Netw2007;5:104–111.
HoffmanBMZevonMAD'ArrigoMCCecchiniTB. Screening for distress in cancer patients: the NCCN rapid-screening measure. Psychooncology2004;13:792–799.
Patrick-MillerLJBroccoliTLMuchJKLevineE. Validation of the Distress Thermometer: a single item screen to detect clinically significant psychological distress in ambulatory oncology patients [abstract]. J Clin Oncol2004;22(Suppl 14):Abstract 6024.
RothAJKornblithABBatel-CopelL. Rapid screening for psychologic distress in men with prostate carcinoma: a pilot study. Cancer1998;82:1904–1908.
ZwahlenDHagenbuchNCarleyMI. Screening cancer patients' families with the distress thermometer (DT): a validation study. Psychooncology2008;17:959–966.
GravesKDArnoldSMLoveCL. Distress screening in a multidisciplinary lung cancer clinic: prevalence and predictors of clinically significant distress. Lung Cancer2007;55:215–224.
TuinmanMAGazendam-DonofrioSMHoekstra-WeebersJE. Screening and referral for psychosocial distress in oncologic practice: use of the Distress Thermometer. Cancer2008;113:870–878.
RansomSJacobsenPBBooth-JonesM. Validation of the Distress Thermometer with bone marrow transplant patients. Psychooncology2006;15:604–612.
TraskPCPatersonARibaM. Assessment of psychological distress in prospective bone marrow transplant patients. Bone Marrow Transplant2002;29:917–925.
JanelsinsMCKohliSMohileSG. An update on cancer- and chemotherapy-related cognitive dysfunction: current status. Semin Oncol2011;38:431–438.
WefelJSVardyJAhlesTSchagenSB. International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer. Lancet Oncol2011;12:703–708.
Anderson-HanleyCShermanMLRiggsR. Neuropsychological effects of treatments for adults with cancer: a meta-analysis and review of the literature. J Int Neuropsychol Soc2003;9:967–982.
DeprezSAmantFSmeetsA. Longitudinal assessment of chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning. J Clin Oncol2012;30:274–281.
StewartABielajewCCollinsB. A meta-analysis of the neuropsychological effects of adjuvant chemotherapy treatment in women treated for breast cancer. Clin Neuropsychol2006;20:76–89.
VardyJRourkeSTannockIF. Evaluation of cognitive function associated with chemotherapy: a review of published studies and recommendations for future research. J Clin Oncol2007;25:2455–2463.
AhlesTASaykinAJMcDonaldBC. Cognitive function in breast cancer patients prior to adjuvant treatment. Breast Cancer Res Treat2008;110:143–152.
AhlesTASaykinAJMcDonaldBC. Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve. J Clin Oncol2010;28:4434–4440.
WefelJSLenziRTheriaultRL. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial. Cancer2004;100:2292–2299.
Jean-PierrePWintersPCAhlesTA. Prevalence of self-reported memory problems in adult cancer survivors: a national cross-sectional study. J Oncol Pract2012;8:30–34.
NelsonCJNandyNRothAJ. Chemotherapy and cognitive deficits: mechanisms, findings, and potential interventions. Palliat Support Care2007;5:273–280.
FergusonRJMcDonaldBCRocqueMA. Development of CBT for chemotherapy-related cognitive change: results of a waitlist control trial. Psychooncology2012;21:176–186.
GehringKRoukemaJASitskoornMM. Review of recent studies on interventions for cognitive deficits in patients with cancer. Expert Rev Anticancer Ther2012;12:255–269.
MeyersCAWeitznerMAValentineADLevinVA. Methylphenidate therapy improves cognition, mood, and function of brain tumor patients. J Clin Oncol1998;16:2522–2527.
ShawEGRosdhalRD'AgostinoRBJr. Phase II study of donepezil in irradiated brain tumor patients: effect on cognitive function, mood, and quality of life. J Clin Oncol2006;24:1415–1420.
VardyJWefelJSAhlesT. Cancer and cancer-therapy related cognitive dysfunction: an international perspective from the Venice cognitive workshop. Ann Oncol2008;19:623–629.
LeeSJSchoverLRPartridgeAH. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol2006;24:2917–2931.
JacobsenPBWagnerLI. A new quality standard: the integration of psychosocial care into routine cancer care. J Clin Oncol2012;30:1154–1159.
StantonAL. What happens now? Psychosocial care for cancer survivors after medical treatment completion. J Clin Oncol2012;30:1215–1220.
ZebrackBIsaacsonS. Psychosocial care of adolescent and young adult patients with cancer and survivors. J Clin Oncol2012;30:1221–1226.
NorthouseLWilliamsALGivenBMcCorkleR. Psychosocial care for family caregivers of patients with cancer. J Clin Oncol2012;30:1227–1234.
HollandJCBultzBD. The NCCN Guideline for Distress Management: a case for making distress the sixth vital sign. J Natl Compr Canc Netw2007;5:3–7.